READING, 23rd September 2008 – Archimedes Pharma UK Limited, the UK based, pan-European specialty pharmaceutical company, today announces the launch of Zibor® (bemiparin sodium) to the UK market. A second-generation low molecular weight heparin (LMWH), Zibor is the only LMWH licensed in the UK for post-operative initiation of thromboprophylaxis in any patients undergoing orthopaedic and general surgery. Already used by over 5 million patients worldwide, Zibor enters the UK market as the lowest priced LMWH.
